APA

Gaidzik V. I., Weber D., Paschka P., Kaumanns A., Krieger S., Corbacioglu A., Krönke J., Kapp-Schwoerer S., Krämer D., Horst H., Schmidt-Wolf I., Held G., Kündgen A., Ringhoffer M., Götze K., Kindler T., Fiedler W., Wattad M., Schlenk R. F., Bullinger L., Teleanu V., Schlegelberger B., Thol F., Heuser M., Ganser A., Döhner H. & Döhner K. (20181211). DNMT3A mutant transcript levels persist in remission and do not predict outcome in patients with acute myeloid leukemia. : Leukemia.

Chicago

Gaidzik V I, Weber D, Paschka P, Kaumanns A, Krieger S, Corbacioglu A, Krönke J, Kapp-Schwoerer S, Krämer D, Horst H-A, Schmidt-Wolf I, Held G, Kündgen A, Ringhoffer M, Götze K, Kindler T, Fiedler W, Wattad M, Schlenk R F, Bullinger L, Teleanu V, Schlegelberger B, Thol F, Heuser M, Ganser A, Döhner H and Döhner K. 20181211. DNMT3A mutant transcript levels persist in remission and do not predict outcome in patients with acute myeloid leukemia. : Leukemia.

Harvard

Gaidzik V. I., Weber D., Paschka P., Kaumanns A., Krieger S., Corbacioglu A., Krönke J., Kapp-Schwoerer S., Krämer D., Horst H., Schmidt-Wolf I., Held G., Kündgen A., Ringhoffer M., Götze K., Kindler T., Fiedler W., Wattad M., Schlenk R. F., Bullinger L., Teleanu V., Schlegelberger B., Thol F., Heuser M., Ganser A., Döhner H. and Döhner K. (20181211). DNMT3A mutant transcript levels persist in remission and do not predict outcome in patients with acute myeloid leukemia. : Leukemia.

MLA

Gaidzik V I, Weber D, Paschka P, Kaumanns A, Krieger S, Corbacioglu A, Krönke J, Kapp-Schwoerer S, Krämer D, Horst H-A, Schmidt-Wolf I, Held G, Kündgen A, Ringhoffer M, Götze K, Kindler T, Fiedler W, Wattad M, Schlenk R F, Bullinger L, Teleanu V, Schlegelberger B, Thol F, Heuser M, Ganser A, Döhner H and Döhner K. DNMT3A mutant transcript levels persist in remission and do not predict outcome in patients with acute myeloid leukemia. : Leukemia. 20181211.